Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma

• Andrew D. Kelly,

  Affiliation Division of Hematology/Oncology, Sarcoma Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Susanne B. Breitkopf,

  Affiliation Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

  ⨯
• Min Yuan,

  Affiliation Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

  ⨯
• Jeffrey Goldsmith,

  Affiliation Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Dimitrios Spentzos ,

  Contributed equally to this work with: Dimitrios Spentzos, John M. Asara

  Affiliations Division of Hematology/Oncology, Sarcoma Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• John M. Asara

  Contributed equally to this work with: Dimitrios Spentzos, John M. Asara

  * E-mail: jasara@bidmc.harvard.edu

  Affiliations Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯